Skip to main content
Premium Trial:

Request an Annual Quote

Columbia University, Qiagen Hit Back at Illumina in NGS Patent Fight With New Suit

NEW YORK – Columbia University and Qiagen filed a lawsuit against Illumina for patent infringement today. 

According to the complaint, filed in the US District Court for the District of Delaware, the plaintiffs allege that Illumina makes, uses, and sells nucleotide analogues that infringe US Patent Nos. 10,407,458 and 10,407,459, both titled "Massive parallel method for decoding DNA and RNA."

Columbia was awarded the patents today and Qiagen is the exclusive licensee.

The suit is the latest salvo in a patent fight that began in 2012. Earlier this week, Illumina successfully challenged a patent held by Columbia before the US Patent Trial and Appeals Board in an inter partes review.

The plaintiffs seek monetary damages, royalties, costs and attorney's fees, and an injunction against Illumina, among other relief. They have requested a jury trial.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.